Insider Transactions in Q1 2025 at Guardant Health, Inc. (GH)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 19
2025
|
Musa Tariq Director |
SELL
Open market or private sale
|
Direct |
116
-3.49%
|
$4,988
$43.7 P/Share
|
|
Mar 17
2025
|
Kumud Kalia Chief Information Officer |
SELL
Open market or private sale
|
Direct |
3,500
-15.07%
|
$150,500
$43.16 P/Share
|
|
Mar 15
2025
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
525
-1.36%
|
$22,050
$42.89 P/Share
|
|
Mar 15
2025
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,019
+2.57%
|
-
|
|
Mar 15
2025
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
249
+6.96%
|
-
|
|
Mar 15
2025
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
500
-1.61%
|
$21,000
$42.89 P/Share
|
|
Mar 15
2025
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,401
+4.32%
|
-
|
|
Mar 15
2025
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
387
-0.96%
|
$16,254
$42.89 P/Share
|
|
Mar 15
2025
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,401
+3.37%
|
-
|
|
Mar 15
2025
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
228
-0.97%
|
$9,576
$42.89 P/Share
|
|
Mar 15
2025
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
637
+2.64%
|
-
|
|
Mar 15
2025
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
69
+0.49%
|
-
|
|
Mar 15
2025
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,659
-4.04%
|
$69,678
$42.89 P/Share
|
|
Mar 15
2025
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,272
+3.9%
|
-
|
|
Mar 14
2025
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
34,853
-1.43%
|
$1,463,826
$42.89 P/Share
|
|
Mar 14
2025
|
Helmy Eltoukhy Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
68,769
+2.75%
|
-
|
|
Mar 14
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
34,853
-1.5%
|
$1,463,826
$42.89 P/Share
|
|
Mar 14
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
68,769
+2.87%
|
-
|
|
Mar 04
2025
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
67
+0.86%
|
-
|
|
Mar 03
2025
|
Meghan V. Joyce Director |
SELL
Open market or private sale
|
Direct |
100
-1.29%
|
$4,200
$42.71 P/Share
|
|
Mar 01
2025
|
Terilyn J. Monroe Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,565
-24.48%
|
$275,730
$42.55 P/Share
|
|
Mar 01
2025
|
Terilyn J. Monroe Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,894
+35.7%
|
-
|
|
Mar 01
2025
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,079
-7.57%
|
$129,318
$42.55 P/Share
|
|
Mar 01
2025
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,949
+6.49%
|
-
|
|
Mar 01
2025
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,029
-6.41%
|
$85,218
$42.55 P/Share
|
|
Mar 01
2025
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,686
+15.23%
|
-
|
|
Mar 01
2025
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,566
-3.88%
|
$65,772
$42.55 P/Share
|
|
Mar 01
2025
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,686
+12.35%
|
-
|
|
Mar 01
2025
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,590
-6.52%
|
$66,780
$42.55 P/Share
|
|
Mar 01
2025
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,406
+8.16%
|
-
|
|
Mar 01
2025
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,537
-6.3%
|
$106,554
$42.55 P/Share
|
|
Mar 01
2025
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,108
+15.0%
|
-
|
|
Mar 01
2025
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,042
-4.0%
|
$127,764
$42.55 P/Share
|
|
Mar 01
2025
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,001
+3.7%
|
-
|
|
Feb 28
2025
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
154
+1.44%
|
-
|
|
Feb 20
2025
|
Musa Tariq Director |
SELL
Open market or private sale
|
Direct |
116
-3.63%
|
$5,568
$48.33 P/Share
|
|
Feb 15
2025
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
68
+0.49%
|
-
|
|
Feb 15
2025
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+7.26%
|
-
|
|
Feb 04
2025
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
66
+0.84%
|
-
|
|
Feb 01
2025
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,352
-10.65%
|
$384,192
$46.98 P/Share
|
|
Feb 01
2025
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,863
+21.8%
|
-
|
|
Feb 01
2025
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,361
-6.64%
|
$108,606
$46.98 P/Share
|
|
Feb 01
2025
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,617
+15.7%
|
-
|
|
Jan 31
2025
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
154
+1.46%
|
-
|
|
Jan 17
2025
|
Musa Tariq Director |
SELL
Open market or private sale
|
Direct |
116
-3.79%
|
$4,292
$37.58 P/Share
|
|
Jan 15
2025
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
68
+0.49%
|
-
|
|
Jan 15
2025
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+7.55%
|
-
|
|
Jan 15
2025
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,305
-4.32%
|
$48,285
$37.5 P/Share
|
|
Jan 15
2025
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,309
+9.87%
|
-
|
|
Jan 15
2025
|
Terilyn J. Monroe Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,420
-34.99%
|
$237,540
$37.5 P/Share
|